Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Palisade Bio, Inc. (NASDAQ: PALI)
PALI Stock Predictions and Ratings
WSX Rating:
HOLD
WSX Forecast (1yr):
1%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
336%
PALI Stock Analysis
PALI
PE Ratio:
27.6
PALI
PEG Ratio:
Not Available
PALI
Forward EPS Growth (12 month):
0.00%
PALI
PS Ratio:
PALI
PSG Ratio:
Not Available
PALI
Forward Revenue Growth (12 month):
0.00%
PALI Articles
No data was found